IPO Season Series: - 1

 

 

IPO Season Series: - 1

 

Krsnaa Diagnostics Ltd.

Krsnaa Diagnostics Limited is a large and differentiated diagnostic services provider. It provides a range of technology-enabled diagnostic service such as imaging (Including radiology), pathology/ clinical laboratory, teleradiology services to public and private hospitals, medical colleges, and community health centers across India. It is the fastest-growing diagnostic chain in india on multiple parameters. The company has an extensive network of integrated diagnostic chain in india on multiple parameters. The company has an extensive network of integrated diagnostic center across India primarily in non-metro and lower-tier cities and towns.

 

Krsnaa Diagnostics Key Details:

·        1000+ radiology centers and 500+ pathology centers.

·        More than 70,000 CT/MRI & 5 Lac X-rays per month.

·        Well-trained team of around 1000 employees.

·        Advanced, fully-automatic machines, our pathology labs and centers.

·        Performing more than 500000 tests per month across the country.

 

 

My Review

·        Apply with Listing Gain and for long Term gain also.

·        Apply on Last day after checking subscription. (High Subscription=High Listing Gain).

  

Krsnaa Diagnostics IPO Date & Price Band

 

 IPO Open:

 04 August 2021

 IPO Close:

 06 August 2021

 IPO Size:

 Approx ₹1213.33 Crores

 Fresh Issue:

 Approx ₹400 Crores

 Offer for Sale:

 Approx ₹813.33 Crores (9,416,377 shares)

 Face Value:

 ₹5 Per Equity Share

 Price Band:

 ₹933 to ₹954 Per Share

 Listing on:

 BSE & NSE

 Retail Portion:

 10%

 Discount:

 ₹93 Per Equity Shares for Employees

 

 

 

Krsnaa Diagnostics IPO Market Lot

The Krsnaa Diagnostics IPO minimum market lot is 15 shares with ₹14,310 application amount. The retail investors can apply up-to 13 lots, 195 shares with ₹186,030 application amount.

 

                  

Minimum Lot Size:

 Minimum 15 Shares

 Minimum Amount:

 ₹14,310 

 Maximum Lot Size:

 Maximum 195          Shares   

 Maximum Amount:

 ₹186,030

 

Krsnaa Diagnostics IPO Date, Time Table, Allotment & Listing

The Krsnaa Diagnostics IPO date is 04 August 2021 and the IPO close date is 06 August 2021. The allotment date is 11 August 2021 and the IPO may list on 17 August 2021.

 

 

 Price Band Announcement:

 30 July 2021

 Anchor Investors Allotment:

 03 August 2021

 IPO Open Date:

 04 August 2021

 IPO Close Date:

 06 August 2021

 Basis of Allotment:

 11 August 2021

 Refunds:

 12 August 2021

 Credit to Demat Account:

 13 August 2021

 IPO Listing Date:

 17 August 2021

Strengths

·        Unique and scaled diagnostics company

·        Brand is associated with providing quality and reliable healthcare services at affordable prices.

·        As of December 31, 2010, its network of diagnostics centers spans 13 states across India in over 1,800 locations

·        Business model with robust revenue visibility.

·        Well-positioned to capitalize on healthcare spending across public and private sectors.

·        Scalable and agile business model with an efficient cost structure.

·        Consistent track record of financial performance.

·        Ability to maintain cost competitiveness through operating leverage.

·        Experienced promoters and management team supported by a strong employee base.

 

Risk

·        Significant dependence on payment under contract with public health agencies.

·        Most of its diagnostic centers have been established and are operated under PPP contracts awarded by government agencies through a competitive bidding process. Company may not successfully win these tenders in the future. Company may not successfully win these tenders in the future.

·        Continuing impact of the outbreak of the COVID-19.

·        Dependency on its information technology systems and the telecommunication network in india in providing diagnostic services and managing its operations.

·        Price charged for the diagnostic services are dependent on recommended or mandatory fees fixed under the terms of the agreements entered into the public and private healthcare providers

·        Capital-intensive business

·        Any failure to comply with the legal and regulatory requirements.

·        Failure to establishment of diagnostic centers results in the termination of the agreements or cost overruns.

·        Highly competitive industry – the diagnostic industry in india.

 

Company Revenue Report

 

₹ in Crores

 

 

 

 

 

Assets

Revenue

Expenses

PAT

PBT

Tax

2018.00

290.00

110.00

 

-60.16

 

 

2019.00

529.00

214.00

 

-58.06

 

 

2020.00

630.00

271.00

429.00

-111.95

-158.00

(45.00)

2021.00

605.00

661.00

366.00

184.93

295.00

110.00

 

Comments

Popular posts from this blog

Mirae Fund House - Best Mutual Funds